Horizon Therapeutics today opened its new global headquarters in Dublin and announced the creation of up to 100 jobs in Dublin and Waterford over the next 18 months.
Horizon is focused on the discovery, development and commercialization of medicines that address the critical needs of people affected by rare, autoimmune and serious inflammatory diseases.
The company’s new 62,000 square foot facility is located at 70 St Stephen’s Green in Dublin city centre.
Horizon’s global headquarters has been in Dublin since 2014 and now employs around 200 people in Ireland in a variety of key roles including finance, legal, technical operations and research and development.
Last year, the company purchased a 44,000-square-foot manufacturing facility in Waterford to support the growth of its rare disease drugs and biologics in development in the market.
Timothy P Walbert, Chairman and CEO of Horizon, said that Ireland has been a wonderful place for Horizon for almost 10 years.
“As a company, we benefit greatly from the rich pool of talented and enthusiastic employees here,” said Walbert.
“Ireland is a key part of our global strategy and we will continue to invest significantly here to enhance our business and demonstrate our support for the wider community,” he added.
Taoiseach Micheál Martin said he welcomed the company’s commitment to create an additional 100 new jobs in Dublin and Waterford.
“The company’s decision to add a manufacturing facility in Waterford last year further underscores the leadership role Ireland plays in the company’s operations. Horizon’s drive and commitment to innovation and its highly skilled workforce and talented people here will continue to bring the company considerable success in the years ahead,” added the Taoiseach.
Martin Shanahan, CEO of IDA Ireland, said that Horizon is one of the next generation of high-growth biotech companies and that its investment and job creation in both its global headquarters in Dublin and its advanced manufacturing facility in Waterford are very welcome and add to the growing biopharmaceutical industry in Ireland. industry.